New Industrial Biomanufacturing Analysis Released
A report outlines three primary production routes for bio-based chemicals to displace traditional fossil-fuel methods.
Updated on Sept. 30, 2026 in Chemistry
Live Poll
Would you prioritize purchasing bio-based products over traditional alternatives if prices were similar?
A report from IDTechEx has detailed the state of industrial biomanufacturing, highlighting three core production methods used to create bio-based alternatives for the global chemical sector. The analysis examines 35 specific biomanufactured molecules produced across the industry.
Why it matters
The chemicals industry produces over one billion metric tons annually, and shifting these processes to bio-based alternatives requires balancing technical risk with economic viability. Hybrid manufacturing routes are emerging as a primary strategy to integrate biological processes into existing industrial infrastructure.
The report evaluates three distinct routes: direct biomanufacturing via fermentation, hybrid manufacturing combining fermentation with chemical synthesis, and conventional chemical synthesis using biomass.
The players
IDTechEx
An analyst firm focused on emerging technology markets and industrial manufacturing trends.
The details
Direct biomanufacturing utilizes microbial fermentation—the process by which microorganisms convert sugars into chemical products—or enzymatic catalysis to transform renewable biomass. Hybrid routes mitigate technical risk by generating intermediates through fermentation before applying established chemical synthesis techniques. Engineered metabolic pathways, such as those used in E. coli to produce 1,4-butanediol, demonstrate how synthetic biology is being applied to mimic or outperform traditional catalytic methods.
Timeline
2027-2037: Forecast period covered by the IDTechEx report.
The Tech Race
The sector remains focused on overcoming the economic constraints of established fossil-derived alternatives. Industrial adoption hinges on whether biological platforms can provide competitive advantages in specific high-value molecule production.
The transition to bio-based chemicals will likely appear first in industrial supply chains rather than consumer-facing products. Success in this field will depend on achieving cost parity with existing petroleum-derived commodities over the next decade.
The takeaway
Advancements in strain engineering and process optimization are expected to expand the diversity of biologically produced molecules through 2037. Observers should track the economic adoption rates of hybrid manufacturing to see if it reduces the cost gap with fossil-based chemical production.
Further reading
Explore more developments in the field within our Chemistry section.
Source note: This article includes information reported by PlasticsToday.
Live Poll
Would you prioritize purchasing bio-based products over traditional alternatives if prices were similar?
